There are two kinds of businesses that are challenging to value outright.
The first are banks. The second is the focus of this week’s column.
Biotech firms more often than not can look like make-believe businesses. Many have no major...
Editor’s Note: Today’s guest article comes from JC Parets, a Chartered Market Technician and the Founder of TrendLabs.
JC’s stated mission is “to decode market behavior using pure technical analysis to reveal the truth behind every move.” I met...
Back in July, I covered Flowers Foods (NYSE: FLO) in one of my Safety Net columns. At the time, it had been falling for 2 1/2 years and had lost half its value. But the 6.3% yield was...
Let me tell you how it will beThere’s one for you, nineteen for me‘Cause I’m the taxmanShould five percent appear too smallBe thankful I don’t take it all‘Cause I’m the taxman– The Beatles (“Taxman,” 1966)
Sixty years ago, the...
